Citation Impact
Citing Papers
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Early indicators of prognosis in fulminant hepatic failure
1989 Standout
Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia?
1985
Pomegranate Extracts Potently Suppress Proliferation, Xenograft Growth, and Invasion of Human Prostate Cancer Cells
2004
Chemopreventive Effects of Pomegranate Seed Oil on Skin Tumor Development in CD 1 Mice
2003
Review article: the current management of acute liver failure
2009
Lithium anode stable in air for low-cost fabrication of a dendrite-free lithium battery
2019 StandoutNobel
Design and Fabrication of Sub-mm-Sized Modules Containing Encapsulated Cells for Modular Tissue Engineering
2007
Factor VIII expression in liver disease
2003
Dysregulation of growth factor signaling in human hepatocellular carcinoma
2006
Liver fibrosis
2005 Standout
Fatal Autoimmune Hepatitis Induced by Concurrent Loss of Naturally Arising Regulatory T Cells and PD-1-Mediated Signaling
2008 StandoutNobel
The activin axis in liver biology and disease
2006
Hydrogels in Regenerative Medicine
2009 Standout
Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide
2006 Nobel
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases
2003
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
2002
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Intensive Care Unit Management of Patients with Liver Failure
2014
Diagnosis and Management of Autoimmune Hepatitis
2010
Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice
2004
Drug-Induced Hepatotoxicity
2003 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Transcriptional Profiling Reveals Novel Markers of Liver Fibrogenesis
2006
Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations
1990
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation
2003 Standout
Sterile Inflammation in the Liver
2012
Acute kidney injury
2019 Standout
Alginate: Properties and biomedical applications
2011 Standout
Haemostatic abnormalities in patients with liver disease
2002
Disseminated Intravascular Coagulation in Liver Cirrhosis: Fact or Fiction?
1999
Acute Liver Failure
1993
Paracetamol (acetaminophen) poisoning
1995
Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
2006 Standout
Expression of Factor VIII by Murine Liver Sinusoidal Endothelial Cells
1999
Dry double-sided tape for adhesion of wet tissues and devices
2019 StandoutNature
CNS‐specific prostacyclin ligands as neuronal survival‐promoting factors in the brain
1999 StandoutNobel
Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture
2004
Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011
2011
TGFβ in Cancer
2008 Standout
Acetaminophen‐induced acute liver failure
2005 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Drug metabolism and hepatotoxicity.
1991
Beneficial effects of histidine and carnosine on ethanol-induced chronic liver injury
2007
Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions
2004
Paracetamol (acetaminophen) poisoning
1993
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Expansion of CD4+CD25+FoxP3+ regulatory T cells in hepatitis C virus‐related chronic hepatitis, cirrhosis and hepatocellular carcinoma
2010
Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure
2001
Food-Related Illness and Death in the United States
1999 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Cellular therapies for liver replacement
2004
Maturation of the hemostatic system during childhood
1992 Standout
Prostacyclin and Blood Coagulation
1981 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Tissue Engineering
1993 StandoutScience
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin
2011 StandoutNobel
Carbacyclin — A potent stable prost acyclin analogue for the inhibition of platelet aggregation
1980 StandoutNobel
Primary Biliary Cirrhosis
1987 Standout
Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers1
2003
PROSTACYCLIN: A SOLUTION TO SOME PROBLEMS OF EXTRACORPOREAL CIRCULATION
1979 StandoutNobel
PROSTACYCLIN CAN REPLACE HEPARIN IN HÆMODIALYSIS IN DOGS
1978 StandoutNobel
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Adventures and Excursions in Bioassay: The Stepping Stones to Prostacyclin (Noble Lecture)
1983 Nobel
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
Pressure-Sensitive Adhesives: An Introductory Course
2003
The release of β‐ thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery
1981
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
In Vitro Expansion of Human Hepatocytes is Restricted by Telomere-Dependent Replicative Aging
2003
Assessment of Artificial Liver Support Technology
1992
EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN
1982
TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis
1999
Adhesively-bonded joints and repairs in metallic alloys, polymers and composite materials: Adhesives, adhesion theories and surface pretreatment
2003 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
1988
Autoimmune Hepatitis
2006
Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI
2008 Standout
Fulminant hepatic failure: Summary of a workshop
1995
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
2017
Management of fulminant hepatic failure
1992
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
2002 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Indications for orthotopic liver transplantation in fulminant liver failure
1994
Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
1979 StandoutNobel
A Bioartificial Liver--State of the Art
2002 Science
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Prediction of Hepatic Encephalopathy in Paracetamol Overdose: A Prospective and Validated Study
1999
Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.
1981
Nitro-olefin trapping reaction of enolates generated by conjugate addition reaction: short syntheses of PGE1, 6-Oxo-PGE1, 6-Oxo-PGF1α, and PGI2
1987 StandoutNobel
Orthotopic liver transplantation for acute and subacute hepatic failure in adults
1987
Tribochemical synthesis of nano-lubricant films from adsorbed molecules at sliding solid interface: Tribo-polymers from α-pinene, pinane, and n-decane
2016
ADP Receptors on Platelets
1996
Three-component coupling synthesis of prostaglandins. A simplified, general procedure
1990 StandoutNobel
Works of P.G. Langley being referenced
Extent of the acute phase response in fulminant hepatic failure.
1994
Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.
1992
Pilot–Controlled Trial of the Extracorporeal Liver Assist Device in Acute Liver Failure
1996
Hyaluronic acid and endothelial damage due to paracetamol‐induced hepatotoxicity
2003
Plasma Cytokine Levels and Coagulation and Complement Activation During Use of the Extracorporeal Liver Assist Device in Acute Liver Failure
1998
Transforming Growth Factor-Beta 1, Activin and Follistatin in Patients with Hepatocellular Carcinoma and Patients with Alcoholic Cirrhosis
2002
Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis
2002
Coagulation Factor V Levels As A Prognostic Indicator in Fulminant Hepatic Failure
1996
Thrombin—antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome
1990
Why a pomegranate?
2000
Plasma levels and hepatic mRNA expression of transforming growth factor-β1 in patients with fulminant hepatic failure
1997
Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.
1977
Platelet function during haemoperfusion in acute liver failure
1980
Mechanism for the action of tackifying resins in pressure‐sensitive adhesives
1973
PROSTACYCLIN TO PREVENT PLATELET ACTIVATION DURING CHARCOAL HÆMOPERFUSION IN FULMINANT HEPATIC FAILURE
1980
Activation of the fibrinolytic system in patients with fulminant liver failure
1993
Assay, kinetics and properties of plasma adenosine diphosphatase. The relationship to acid and alkaline phosphatase and variations in disease
1982
CHARCOAL HÆMOPERFUSION IN THE TREATMENT OF FULMINANT HEPATIC FAILURE
1974
Platelet function in chronic liver disease
1979
Increased Factor VIII Complex in Fulminant Hepatic Failure
1985
Coagulopathy of Fulminant Hepatic Failure
1986
Determination of the ketone body ratio in fulminant hepatic failure.
1990
The Effect of Fulminant Hepatic Failure on Protein C Antigen and Activity
1988
Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure
1991
Effect of ELAD Liver Support on Plasma HGF and TGF–β1 in Acute Liver Failure
1996